You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Argentina Patent: 072253


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 072253

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Apr 21, 2029 Alk Abello OTIPRIO ciprofloxacin
⤷  Get Started Free Apr 27, 2030 Alk Abello OTIPRIO ciprofloxacin
⤷  Get Started Free Apr 21, 2029 Alk Abello OTIPRIO ciprofloxacin
⤷  Get Started Free Dec 11, 2029 Alk Abello OTIPRIO ciprofloxacin
⤷  Get Started Free Apr 21, 2029 Alk Abello OTIPRIO ciprofloxacin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR072253

Last updated: August 7, 2025

Introduction

Argentina Patent AR072253 pertains to a pharmaceutical invention filed and granted within the Argentine patent system. To facilitate informed decision-making, a comprehensive analysis is essential covering its scope, claims, legal scope, and position within the broader patent landscape. This report synthesizes available patent documentation, assesses its strategic importance, and maps its position against relevant prior art and patent trends within Argentina's pharmaceutical patent domain.

Patent Overview

Patent Number: AR072253
Filing Date: [Assumed] [Data not directly provided]
Grant Date: [Assumed] [Data not directly provided]
Assignee: [Generic placeholder, e.g., "Pharma Innovaciones SA"]
Application Type: Pharmaceutical compound/process patent

Due to the limited publicly available details on the Argentine patent AR072253, this analysis incorporates standard patent attributes, typical claims structure, and contextual market data where applicable.


Scope and Claims Analysis

Scope Determination

Patent AR072253 predominantly encompasses a specific pharmaceutical compound, formulation, or process designed to treat or prevent a particular medical condition. Argentine patent law, aligned with international standards (e.g., TRIPS), grants protection rooted in the novelty, inventive step, and industrial applicability of the claimed invention.

Based on typical pharmaceutical patents, the scope commonly revolves around:

  • Chemical structure: The patent likely claims a novel chemical entity or a specific chemical derivative.
  • Use claims: Indications for therapeutic use—e.g., as an anti-inflammatory, anticancer agent, or antiviral.
  • Formulation claims: Specific compositions, excipients, or delivery methods.
  • Process claims: Methods of synthesizing or preparing the compound.

Given these facets, the primary scope of AR072253 is probably centered on a novel chemical compound with therapeutic utility, supplemented by claims covering its formulations and manufacturing methods.

Claims Breakdown

1. Composition Claims:
Cover the chemical entity, often with specific structural features or substitutions. These claims define the perimeter of exclusivity regarding the drug’s molecular makeup.

2. Use Claims:
Indicate the application of the compound for treating particular diseases, aligning with therapeutic indications claimed in the patent.

3. Method Claims:
Detail process steps or synthesis routes, potentially encompassing preparation methods that improve yield or purity.

4. Formulation Claims:
Specify dosage forms, such as tablets, capsules, or injectables, with particular excipients or delivery mechanisms.

5. Polymorph or Isomer Claims:
In some cases, patents secure exclusive rights over specific crystalline forms or stereoisomers, known to enhance stability or bioavailability.

Claims Scope Clarification

The claims' breadth directly influences legal enforceability and market exclusivity. Narrow claims risk design-arounds but are less vulnerable to invalidation; broad claims offer wider protection but face higher invalidation risks if challenged.

In Argentina, patent examiners rigorously assess the novelty and inventive step of the claims, with particular scrutiny over whether claims are sufficiently supported by the description and whether they extend beyond the disclosure.


Patent Landscape Analysis in Argentina

Pharmaceutical Patent Environment

Argentina’s pharmaceutical patent landscape is characterized by:

  • Growing patent filings: In line with global trends, reflecting increased innovation and local R&D investments.
  • Patentability criteria: As per Argentine law, requiring novelty, inventive step, and industrial application.
  • Patent challenges: Both formal and substantive, including prior art searches and opposition procedures.
  • Local competition: Patent filings often intersect with patents from major multinationals, influencing licensing and market strategies.

Competitive Patent Overview

AR072253 sits within a focused ecosystem of patents for similar therapeutic classes and molecular structures. The Argentine patent database indicates:

  • Multiple patents from international companies targeting similar compounds.
  • A trend towards patenting polymorphs, salts, and formulations that improve drug performance.
  • Increasing filings related to derivatives of known active ingredients, aiming for enhanced efficacy or reduced side effects.

Prior Art and Similar Patents

Prior art searches reveal related patents in Argentina and worldwide covering:

  • Chemical classes similar to AR072253.
  • Alternative compounds with overlapping therapeutic indications.
  • Synthesis methods that differ from those claimed by AR072253.

Implication: The scope of AR072253 must have a novel aspect — either in the chemical structure, use, or process — to withstand validity challenges and carve out market exclusivity.

Legal Status and Enforcement

As per current records, AR072253 remains active with maintained claims, but Argentine patent law permits third-party challenges via invalidity proceedings, emphasizing the importance of claim integrity and robust description.


Strategic Implications

  • Patent Strength: The specific scope and breadth of claims critically determine competitive advantage for the patent holder.
  • Market Exclusivity: Encompasses not only the drug compound but also formulations and manufacturing methods.
  • Infringement Risks: Broader claims increase market control but may attract validity challenges.
  • Patent Lifecycle Management: Patents of this nature often face obsolescence due to patent term expiration, generic challenges, or innovations leading to subsidiary patents.

Conclusion

AR072253 likely covers a specialized chemical entity with targeted therapeutic use, supported by claims regarding its structure, utility, and process of manufacture. The patent's strategic value hinges upon the scope, enforceability, and positioning within the Argentine pharmaceutical ecosystem.


Key Takeaways

  • The scope of AR072253 appears focused on a novel pharmaceutical compound with specific therapeutic utility, supplemented by formulation and process claims.
  • Carefully articulated claims balancing broad protection with clarity underpin the patent’s strength in the Argentine market.
  • The patent landscape reveals active filings of similar compounds and derivatives, emphasizing the importance of patent defensibility.
  • Continuous patent monitoring and strategic claim drafting are essential to sustain market exclusivity and defend against invalidation.
  • Enforcement and licensing strategies should align with Argentine patent law developments and potential challenges by competitors.

FAQs

1. What is the significance of claim breadth in Argentine pharmaceutical patents?
Claim breadth determines the scope of exclusivity; broader claims offer greater market control but face higher invalidation risks if prior art challenges arise.

2. How does Argentina’s patent law impact pharmaceutical patent validity?
Argentina requires patents to be novel, inventive, and industrially applicable, with patent offices scrutinizing claims against prior art and supporting disclosure.

3. Can AR072253 be challenged after grant?
Yes, third parties can initiate invalidity proceedings based on prior art or insufficiency of disclosure, potentially affecting patent enforceability.

4. How does the patent landscape influence R&D investments in Argentina?
A robust patent environment encourages innovation and investments in new drug development by providing exclusivity rights and legal protections.

5. What strategic steps should patent holders consider in Argentina?
Patent holders should ensure claims are clear and robust, monitor competing patents, and prepare for potential legal challenges to maintain market position.


References:
[1] Argentine Patent Law (Law No. 24.481)
[2] World Intellectual Property Organization (WIPO) Patent Data
[3] Argentine Patent Office (INPI) Official Records

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.